Gene therapy immunovaccine with B7-2 and GM-CSF: Phase I Update

Tumor cells will be taken from patients diagnosed with recurring glioblastoma or melanoma,

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE